Preview

Meditsinskiy sovet = Medical Council

Advanced search

Pain in angina attack

https://doi.org/10.21518/2079-701X-2014-12-49-53

Abstract

For many years, coronary heart disease (CHD) has been the main cause of death in many developed countries. At present, cardiovascular diseases (CVD) play a crucial role in the evolution of total mortality in Russia. CVD mortality in Russia in 2013 amounted to 857 cases per 100 thousand residents, of which nearly 50% were deaths from coronary heart disease. CVD treatment and relief of clinical manifestations are among the priority tasks in modern cardiology.

About the Author

MV Kuznetsova
National Research Center for Preventive Medicine
Russian Federation


References

1. Рекомендации Европейского общества кардиологов - 2013.

2. Беленков Ю.Н., Оганов Р.Г. Национальное руководство по кардиологии. ГЭОТАР-Медиа, 2012.

3. Мазур Н. Роль нитратов в лечении кардиологических больных в соответствии с принципами доказательной медицины и рекомендации по их практическому применению. Медиасфера, 2007.

4. Змушко Е.И., Белозеров Е.С. Лекарственные препараты. СПб.: Питер, 2000.

5. Косарев В.В. Фармакотерапия. Самара: Медицина, 1994.

6. Машковский М.Д. Лекарственные средства: В 2 т. Т. 1. М.: Новая волна, 2002.

7. Синев Д.Н., Гуревич И.Я. Пособие для фармацевтов аптек. М.: Медицина, 1982.

8. Фармакологический словарь. Сост. П.М. Фадеева. М.: Медицина, 2003.

9. Moncada S, Higgs A. The L-arginine - nitric oxide pathway. N Engl J Med., 1993, 329: 2002-2012.4.

10. Cohn JN, Archibald DG, Zische S et al. Effect of vasodilator therapy on mortality in chronic congestive heart failure: results of veterans administration Cooperative Study. A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure. N Engl J Med, 1991, 325: 303-310.

11. Horowitz JD. Tolerance induction during therapy with long - acting nitrates: how extensive is the «Collateral demage»? Cardiovasc Drugs Ther, 2004, 18: 1: 11-12.16.

12. Kosmicki MA, Szwed H, Sadowski Z. Antiischemic response to sublingual nitroglycerin during oral administration of isosorbide dinitrate in patients with stable angina pectoris: when does cross tolerance occur? Cardiovasc Drugs Ther, 2004, 18: 1: 47-55.17.

13. Webb DJ, Muirhead GJ, Wulff M et al. Sildenafil citrate potentiates the hypotensive effects of nitric oxide donor drugs in male patients with stable angina. J Am Coll Cardiol, 2000, 36: 25-31.

14. Doucet S, Malekianpour M, Theroux P et al. Randomized trial comparing intravenous nitroglycerin and heparin for treatment of unstable angina secondary to restenosis after coronary artery angioplasty Circulation, 2000, 101: 955-61.

15. Bussmann WD, Passek D, Seidel W, Kaltenbach M. Reduction of CK and CK-MB indexes of infarct size by intravenous nitroglycerin. Circulation, 1981, 63: 615-22.


Review

For citations:


Kuznetsova M. Pain in angina attack. Meditsinskiy sovet = Medical Council. 2014;(12):49-53. (In Russ.) https://doi.org/10.21518/2079-701X-2014-12-49-53

Views: 453


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 2079-701X (Print)
ISSN 2658-5790 (Online)